Your browser doesn't support javascript.
loading
Impact of Digitalis Use on Mortality in Japanese Patients With Non-Valvular Atrial Fibrillation - A Subanalysis of the J-RHYTHM Registry.
Kodani, Eitaro; Inoue, Hiroshi; Atarashi, Hirotsugu; Okumura, Ken; Yamashita, Takeshi; Origasa, Hideki.
Afiliación
  • Kodani E; Department of Internal Medicine and Cardiology, Nippon Medical School Tama-Nagayama Hospital.
  • Inoue H; Saiseikai Toyama Hospital.
  • Atarashi H; Department of Internal Medicine and Cardiology, Nippon Medical School Tama-Nagayama Hospital.
  • Okumura K; Saiseikai Kumamoto Hospital.
  • Yamashita T; The Cardiovascular Institute.
  • Origasa H; Division of Biostatistics and Clinical Epidemiology, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences.
Circ J ; 83(8): 1644-1652, 2019 07 25.
Article en En | MEDLINE | ID: mdl-31217399
BACKGROUND: Because the influence of digitalis use on the death of patients with non-valvular atrial fibrillation (NVAF) remains controversial, a subanalysis of the J-RHYTHM Registry was performed.Methods and Results:A consecutive series of outpatients with AF from 158 institutions was enrolled and followed for 2 years or until the occurrence of an event. Among 7,406 patients with NVAF, 7,018 (age, 69.7±10.0 years; men, 71.1%) with information on antiarrhythmic drug and digitalis use at baseline were divided into 2 groups based on digitalis use. The influence of digitalis on death was investigated using a propensity score-matching model. In 802 patients treated with digitalis, all-cause death was significantly higher than in 6,216 patients with no digitalis use during the 2-year follow-up period (4.4% vs. 2.4%, unadjusted P<0.001). Digitalis use was significantly associated with all-cause death in the crude model (hazard ratio [HR] 1.85, 95% confidence interval [CI] 1.28-2.68, P=0.001). However, after propensity score-matching, the association was not significant (HR 1.31, 95% CI 0.70-2.46, P=0.405). Older age, male sex, heart failure, coronary artery disease, and lower body mass index were significantly associated with all-cause death in NVAF patients treated with digitalis. CONCLUSIONS: Digitalis use was not independently associated with all-cause death, and several clinical confounding factors might contribute to increased mortality in NVAF patients treated with digitalis.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Trastornos Cerebrovasculares / Digitalis / Glicósidos Digitálicos / Antiarrítmicos Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Circ J Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Trastornos Cerebrovasculares / Digitalis / Glicósidos Digitálicos / Antiarrítmicos Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Circ J Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Japón